Private Trust Company’s RxSight RXST Stock Holding History

Private Trust Company’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.16K	Hold	1,000	–	–	﹤0.01%	2141
2025 Q4	$10.4K	Hold	1,000	–	–	﹤0.01%	1914
2025 Q3	$8.99K	Hold	1,000	–	–	﹤0.01%	1950
2025 Q2	$13K	Hold	1,000	–	–	﹤0.01%	1723
2025 Q1	$25.3K	Hold	1,000	–	–	﹤0.01%	1460
2024 Q4	$34.4K	Buy	+1,000	New	+$45.1K	﹤0.01%	1304

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Private Trust Company's RXST Position: Q1 2026 in Review

Private Trust Company held its RxSight (RXST) position steady in Q1 2026 at 1,000 shares worth $6.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Private Trust Company first reported a position in RXST in Q4 2024 and has held it in 6 quarters since. The position peaked at $34.4K in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Private Trust Company held 1,000 shares of RxSight worth $6.16K as of Q1 2026.
Private Trust Company left its RxSight share count unchanged in Q1 2026.
RxSight made up ﹤0.01% of Private Trust Company's portfolio in Q1 2026, its #2141 holding.
Private Trust Company first reported a position in RxSight in Q4 2024 and has held it in 6 quarters since.
Private Trust Company's RxSight position peaked at $34.4K in Q4 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.